Ossiam Regeneron Pharmaceuticals, Inc. Transaction History

Ossiam

$5.59 Billion
Q4 2024

A detailed history of Ossiam transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ossiam holds 16,173 shares of REGN stock, worth $11.5 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

16,173

Previous 17,170 5.81%

Holding current value

$11.5 Million

Previous $18 Million 36.17%

% of portfolio

0.21%

Previous 0.35%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$701.85 - $1046.91 $699,744 - $1.04 Million	-997 Reduced 5.81%	16,173 $11.5 Million
Q3 2024 Nov 13, 2024	SELL	$1024.09 - $1201.76 $770,115 - $903,723	-752 Reduced 4.2%	17,170 $18 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $11 Million - $13.4 Million	12,493 Added 230.12%	17,922 $18.8 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $272,612 - $299,991	302 Added 5.89%	5,429 $5.23 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $1.02 Million - $1.17 Million	1,322 Added 34.74%	5,127 $4.5 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $25.7 Million - $31.3 Million	-37,071 Reduced 90.69%	3,805 $3.13 Million
Q2 2023 Aug 11, 2023	BUY	$700.03 - $830.35 $26.4 Million - $31.3 Million	37,664 Added 1172.6%	40,876 $29.4 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $1.57 Million - $1.91 Million	2,312 Added 256.89%	3,212 $2.64 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $510,358 - $554,099	-723 Reduced 44.55%	900 $649,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $223,274 - $281,760	-389 Reduced 19.33%	1,623 $1.12 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $3.58 Million - $4.82 Million	-6,528 Reduced 76.44%	2,012 $1.19 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $9,521 - $11,174	16 Added 0.19%	8,540 $5.97 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $336,957 - $416,001	620 Added 7.84%	8,524 $5.38 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $1.6 Million - $1.9 Million	-2,783 Reduced 26.04%	7,904 $4.78 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $838,747 - $990,849	1,774 Added 19.9%	10,687 $6.14 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $3.95 Million - $4.85 Million	8,841 Added 12279.17%	8,913 $4.22 Million
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $1.91 Million - $2.43 Million	-4,003 Reduced 98.23%	72 $35,000
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $1.37 Million - $1.65 Million	-2,511 Reduced 38.13%	4,075 $2.28 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $1.15 Million - $1.5 Million	2,335 Added 54.93%	6,586 $4.11 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $1.38 Million - $2.03 Million	4,111 Added 2936.43%	4,251 $2.08 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $26,864 - $36,897	-98 Reduced 41.18%	140 $53,000
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $47,308 - $55,081	173 Added 266.15%	238 $66,000
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $51,830 - $71,763	-173 Reduced 72.69%	65 $20,000
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $29,022 - $34,286	-78 Reduced 24.68%	238 $98,000
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $106,119 - $127,360	316 New	316 $118,000

Others Institutions Holding REGN

# of Institutions

1,487

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.43M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.

Account